WilmerHale’s DCM team is noted particularly for its experience in the life sciences and tech spaces. Brian Johnson and Lisa Firenze lead the team in New York; both partners have considerable experience leading on emerging company representations. Stuart Falber in Boston is chair of the firm’s life sciences sector and stands out for his work for major players in this space, including both emerging and mature companies as well as investment banks. Molly Fox, also in Boston, is active in both the life sciences and tech sectors, advising companies, underwriters, and venture capital funds on a variety of DCM transactions. Craig Hilts, Cynthia Mazareas, and Caroline Dotolo are also key contacts in the firm’s Boston office.
L’éditorial du Legal 500
- Profil
Clients clés
- Medtronic, Inc.
- State Street Corporation
- MKS Instruments, Inc.
- Analog Devices, Inc.
- Thermo Fisher Scientific
- Agios Pharmaceuticals
- MicroStrategy Incorporated
- Casella Waste Systems, Inc.
- McCormick & Company, Incorporated
- Choice Hotels International, Inc.
Points forts
- Advised Medtronic in its public offering of €850 million aggregate principal amount of 3.650% Senior Notes due 2029, €850 million aggregate principal amount of 3.875% Senior Notes due 2036, €600 million aggregate principal amount of 4.150% Senior Notes due 2043 and €700 million aggregate principal amount of 4.150% Senior Notes due 2053.
- Advised Thermo Fisher Scientific as US special counsel in connection with its inaugural offer and sale of CHF-denominated bonds, in an offering that was the largest issuance by a foreign issuer of Swiss franc bonds in seven years, worth CHF $1.07 billion.
- Advised Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), in its agreement to sell its rights to its 15% royalty on potential $1 billion US net sales of Servier’s vorasidenib to Royalty Pharma.
Avocats
Responsable de la pratique
Brian Johnson; Lisa Firenze
Autres avocats clés
Molly Fox; Craig Hilts; Cynthia Mazareas; Caroline Dotolo